Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
12/2003
12/25/2003US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease
12/25/2003US20030236251 Hepatitis virus viricides
12/24/2003WO2003106430A1 Benzimidazole inhibitors of poly(adp-ribosyl) polymerase
12/24/2003WO2003105781A2 Ophthalmic compositions for treating ocular hypertension
12/24/2003WO2003105779A2 Guanidine compounds as anesthetics and for treatment of nervous system disorders
12/24/2003WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation
12/24/2003CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension
12/24/2003CA2487122A1 Guanidine compounds as anesthetics and for treatment of nervous system disorders
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/23/2003US6667324 Dry blend pharmaceutical formulations
12/23/2003US6667323 Dry-blend pharmaceutical formulations
12/23/2003US6667321 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
12/23/2003US6667307 HIV protease
12/23/2003US6667302 Heterocyclic topoisomerase poisons
12/18/2003WO2003104209A1 Peptide deformylase inhibitors
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003WO2003103598A2 Amidine derivatives for treating amyloidosis
12/18/2003WO2003103398A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
12/18/2003US20030232869 N3 alkylated benzimidazole derivatives as MEK inhibitors
12/18/2003US20030232836 Secondary amides such as 2-(4-(2- methoxyphenyl)-1-piperazinyl )-N-(3-methylphenyl)acetamide, used for prophylaxis of impotency
12/18/2003US20030232816 Benzimidazole derivatives
12/18/2003US20030232810 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003US20030232789 Salicylamides as serine protease and factor xa inhibitors
12/18/2003US20030229950 Hair dyes
12/18/2003CA2488493A1 Amidine derivatives for treating amyloidosis
12/18/2003CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/18/2003CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans
12/17/2003EP1370682A2 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
12/17/2003EP1370542A1 Bicyclic guanidine derivatives and therapeutic uses thereof
12/17/2003EP1370540A1 Anti-thrombotic carboxylic acid amides, the production thereof and use of the same as medicaments
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1189889B1 Compositions and methods for inhibiting cell death
12/17/2003CN1462303A Double-spiro organic compounds and electric-field luminescent devices
12/17/2003CN1131032C Benzimidzole enteric coating preparation and preparing method thereof
12/16/2003US6664353 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
12/11/2003WO2003101970A1 Imidazolium cxcr3 inhibitors
12/11/2003WO2003028721A3 Substituted benzimidazole compounds and their use for the treatment of cancer
12/11/2003WO2003024395A3 Linked biaryl compounds
12/11/2003US20030229132 Small molecule modulators of apoptosis
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229102 Sulfonamide derivatives
12/11/2003US20030229094 Acetamides and benzamides that are useful in treating sexual dysfunction
12/11/2003US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents
12/11/2003US20030229074 Metabolism; eating disorders; sexual disorders
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/10/2003EP1368028A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
12/09/2003US6660870 Serotonergic compounds which possess agonist activity at 5-HT2 receptors effectively lower and control normal and elevated IOP and are useful for treating glaucoma
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660742 Alkylation therapy; anticancer agent
12/04/2003WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099814A1 Calcium receptor modulating agents
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099266A2 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003WO2003075921A3 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/04/2003WO2003066673A8 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
12/04/2003WO2003027130A3 Transition metal complexes for preparing olefin oligomers
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225137 2-pyridinyl)-methyl)sulfinyl)-1H-benzimidazole derivatives
12/04/2003US20030225136 Heterocyclic imines such as (5)6-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H -benzimidazole and salts, used as antisecretory agents
12/04/2003US20030225135 Dry-blend pharmaceutical formulations
12/04/2003US20030225127 Heterocyclic sulfonamide derivatives
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003CA2487017A1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003CA2486564A1 Acetamides and benzamides that are useful in treating sexual dysfunction
12/03/2003EP1367056A1 Drugs that enhance synaptic responses mediated by AMPA receptors
12/03/2003EP1366766A1 Inhibitors of IMPDH enzyme
12/03/2003CN1129583C Compound as intermediates for use in preparation of optically active 2-imidazoline-5-one or 2-imidazoline-5-thionone derivatives
12/02/2003US6656956 Benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656945 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction
12/02/2003CA2246909C Method for chemical synthesis of oligonucleotides
11/2003
11/27/2003WO2003096980A2 Bicyclic modulators of androgen receptor function
11/27/2003WO2003024899A3 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003US20030220521 A conjugate compound comprising an antagonist of adrenergic neurotransmitter, and second residue is capable of being cleaved by a kidney enzyme; sodium channel modulators, hypotensive agents
11/27/2003US20030220372 Imidazole compounds as anti-inflammatory and analgesic agents
11/27/2003US20030220369 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220341 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/27/2003US20030220326 Compounds, pharmaceutical compositions, and methods for inhibiting cyclin-dependent kinases
11/26/2003EP1364945A1 Benzimidazolidinone derivatives
11/26/2003EP1363890A2 Melanocortin-4 receptor binding compounds and methods of use thereof
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP0828487B1 Agents for use against parasitic protozoa
11/26/2003CN1458922A Urea derivative and adhesive-molecule inhibitor containing same as ctive ingredient
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 154